Roche en­lists Monte Rosa for can­cer, neu­ro dis­cov­ery deal with $50M up­front

Roche is forg­ing a new part­ner­ship with a start­up fo­cused on pro­tein degra­da­tion.

The multi­na­tion­al phar­ma com­pa­ny an­nounced Tues­day it is pay­ing $50 mil­lion up­front …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER